Drugs Containing Excipient (Inactive Ingredient) POLYSORBATE 80

Branded drugs containing POLYSORBATE 80 excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Eli Lilly and Company	ZYPREXA	olanzapine	0002-4112	POLYSORBATE 80
Eli Lilly and Company	EVISTA	raloxifene hydrochloride	0002-4184	POLYSORBATE 80
ER Squibb & Sons LLC	KENALOG-40	triamcinolone acetonide	0003-0293	POLYSORBATE 80
ER Squibb & Sons LLC	KENALOG-10	triamcinolone acetonide	0003-0494	POLYSORBATE 80
ER Squibb & Sons LLC	BARACLUDE	entecavir	0003-1611	POLYSORBATE 80
Genentech Inc	VALCYTE	valganciclovir	0004-0038	POLYSORBATE 80
Merck Sharp & Dohme LLC	EMEND	fosaprepitant dimeglumine	0006-3061	POLYSORBATE 80

Generic drugs containing POLYSORBATE 80 excipient

Company	Ingredient	NDC	Excipient
Eli Lilly and Company	dulaglutide	0002-1433	POLYSORBATE 80
Eli Lilly and Company	galcanezumab-gnlm	0002-1436	POLYSORBATE 80
Eli Lilly and Company	ixekizumab	0002-1445	POLYSORBATE 80
Eli Lilly and Company	olanzapine	0002-4112	POLYSORBATE 80
Eli Lilly and Company	raloxifene hydrochloride	0002-4184	POLYSORBATE 80
Eli Lilly and Company	mirikizumab-mrkz	0002-7575	POLYSORBATE 80
Eli Lilly and Company	ramucirumab	0002-7669	POLYSORBATE 80

Market Dynamics and Financial Trajectory of Polysorbate 80

Last updated: February 20, 2026

Polysorbate 80, a nonionic surfactant widely used as an emulsifier and stabilizer in pharmaceuticals, food, and cosmetics, has experienced steady growth driven by expanding applications and regulatory approvals. The global market grew from approximately $600 million in 2021 to over $750 million in 2022, reflecting a compound annual growth rate (CAGR) of around 8.3%. Demand is primarily fueled by increasing pharmaceutical production, rising adoption in vaccine formulations, and surge in consumer health products.

Market Size and Forecast

Year	Estimated Market Size	CAGR (2022-2027)	Key Drivers
2021	$600 million	-	Established use; mature market
2022	$750 million	8.3%	Vaccine development, healthcare investment
2023	$810 million	7.8%	Increased regulatory approvals
2027	$1.2 billion	~12%	Growing pharmaceutical pipeline

Source: MarketResearch.com, 2023

Application Segments

Pharmaceuticals

Polysorbate 80 functions as an emulsifier for vaccines (notably mRNA and protein-based vaccines), stabilizer for injectables, and excipient in biosimilars. Its demand in vaccine manufacturing rose by 25% in 2021-2022 due to COVID-19 immunization efforts.

Food Industry

It serves as an emulsifier in baked goods, dairy products, and convenience foods, accounting for approximately 40% of its market volume.

Cosmetics and Personal Care

In creams, lotions, and hair products, Polysorbate 80 ensures homogeneity and stability. This segment's growth is fueled by innovations in skincare and increased consumer health consciousness.

Regional Market Trends

Region	Market Share (2022)	Growth Rate (2022-2027)	Key Factors
North America	38%	7-9%	High pharmaceutical R&D investment
Europe	25%	6-8%	Strict regulatory standards
Asia-Pacific	30%	10-12%	Growing manufacturing base in India, China
Rest of the World	7%	5-7%	Emerging markets, local production

Supply Chain and Production

Major suppliers include BASF, Croda International, and Evonik. Capacity expansions occurred in 2020-2022, with new facilities in India and China increasing regional supply resilience. Raw material costs, primarily of sorbitol and ethoxylation reagents, have also risen by approximately 15% since 2020, affecting manufacturing margins.

Competitive Landscape

Company	Market Share	Notable Developments
BASF	35%	Investment in sustainable production methods
Croda International	25%	Diversification into specialty surfactants
Evonik	15%	Capacity expansion in Asia
Others	25%	Regional private-labels

Regulatory and Patent Environment

Polysorbate 80 is GRAS (Generally Recognized as Safe) in food and approved for pharmaceutical use by the FDA and EMA. No recent patent expirations impact market exclusivity. Patents related to process improvements and new formulations are active through 2025-2030, signaling ongoing innovation.

Financial Outlook

Manufacturers report gross margins of approximately 25-30% per kilogram of Polysorbate 80, with margins narrowing slightly due to raw material costs. Companies with capacity expansion plans project revenue growth between 10-15% annually through 2025, driven by capacity scaling and new application development.

Risks and Challenges

• Regulatory delays in emerging markets.
• Raw material price volatility impacting profit margins.
• Increasing emphasis on sustainability, requiring process modifications.
• Competition from alternative emulsifiers, especially in clean-label formulations.

Key Takeaways

• The Polysorbate 80 market grows annually at approximately 8-12%, with regional variations.
• Demand is tightly linked to pharmaceutical applications, especially vaccine manufacturing.
• Suppliers expanding capacity in Asia face rising raw material costs.
• Innovation in manufacturing processes and formulations sustains competitive differentiation.
• Regulatory stability supports steady market expansion; emerging markets pose growth opportunities and risks.

FAQs

1. What are the main applications driving Polysorbate 80 demand?
Primarily pharmaceuticals (vaccines and parenteral drugs), food emulsifiers, and cosmetic stabilizers.

2. How do raw material costs impact profitability?
Rising costs for sorbitol and ethoxylation reagents reduce margins unless offset by price increases or process efficiencies.

3. What are the key growth regions for Polysorbate 80?
Asia-Pacific leads with growth rates of 10-12%, followed by North America and Europe with 6-9%.

4. Are there significant patent expirations affecting Polysorbate 80?
No recent patent expirations; process patents are active through 2025-2030, enabling ongoing innovation.

5. How might sustainability trends influence market supply?
Increased investment in eco-friendly production methods may require capital expenditure but could offer long-term cost advantages.

---

Sources:

[1] MarketResearch.com. (2023). Global Polysorbate Market Outlook.

[2] Transparency Market Research. (2023). Polysorbate Market Forecast.

[3] FDA. (2022). GRAS Notices on Polysorbate 80.

[4] European Medicines Agency. (2022). Regulatory Status of Pharmaceutical Excipients.